Here, GLP-1RAs are one exciting option [28]
Tirzepatide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 5 days (120 hours) Peak concentration: 8 to 72 hours after injection Recommended timing approach: The shorter half-life compared to semaglutide means the end-of-week trough is more noticeable
Here is what you should know before you decide
Combination approaches using local injection for one peptide and systemic for the other represent another valid strategy
Yu M, Henning R, Walker A, Kim G, Perroy A, Alessandro R, Virador V, Kohn EC
Women should stop the medication at least 2 months before attempting pregnancy